about
Mucins in ovarian cancer diagnosis and therapyLinear and branched glyco-lipopeptide vaccines follow distinct cross-presentation pathways and generate different magnitudes of antitumor immunityA cancer therapeutic vaccine based on clustered Tn-antigen mimetics induces strong antibody-mediated protective immunity.Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer.
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Mucins as immunogenic targets in cancer.
@ast
Mucins as immunogenic targets in cancer.
@en
type
label
Mucins as immunogenic targets in cancer.
@ast
Mucins as immunogenic targets in cancer.
@en
prefLabel
Mucins as immunogenic targets in cancer.
@ast
Mucins as immunogenic targets in cancer.
@en
P2093
P1433
P1476
Mucins as immunogenic targets in cancer.
@en
P2093
Karayiannakis AJ
Syrigos KN
P304
P407
P577
1999-11-01T00:00:00Z